Author Question: Why do ABAB designs aid in making conclusions about the effects of treatment? a) Because ABAB ... (Read 76 times)

yoroshambo

  • Hero Member
  • *****
  • Posts: 566
Why do ABAB designs aid in making conclusions about the effects of treatment?
 
  a) Because ABAB designs do not require a baseline assessment.
  b) Because ABAB designs show the effects of no treatment over time.
  c) Because the reversal phase and corresponding changes in behavior usually make rival hypotheses implausible.
  d) Because the reversal phase demonstrates that the behavior change will not revert to previous levels

Question 2

Why is variability in the data at baseline assessment problematic in single-case designs?
 
  a) Because performance at baseline indicates whether the treatment will be effective for the given participant.
  b) Because performance at baseline allows the investigator to generalize the findings to others in the population.
  c) Because performance at baseline is used to predict future performance and variability makes prediction difficult.
  d) Because performance at baseline is used to predict past performance and variability makes prediction difficult.



AngeliqueG

  • Sr. Member
  • ****
  • Posts: 343
Answer to Question 1

Correct Answer: c

Answer to Question 2

Correct Answer: c



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Astigmatism is the most common vision problem. It may accompany nearsightedness or farsightedness. It is usually caused by an irregularly shaped cornea, but sometimes it is the result of an irregularly shaped lens. Either type can be corrected by eyeglasses, contact lenses, or refractive surgery.

Did you know?

Medication errors are three times higher among children and infants than with adults.

Did you know?

Egg cells are about the size of a grain of sand. They are formed inside of a female's ovaries before she is even born.

Did you know?

Elderly adults are at greatest risk of stroke and myocardial infarction and have the most to gain from prophylaxis. Patients ages 60 to 80 years with blood pressures above 160/90 mm Hg should benefit from antihypertensive treatment.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

For a complete list of videos, visit our video library